Japanese Luxury Stock News

Event overview and why Seiko Group stock is in focus Seiko Group (TSE:8050) has drawn fresh attention after stating that it is considering a reduction in its investment unit. The company described this potential change as a way to broaden its investor base and improve share liquidity. See our latest analysis for Seiko Group. Investors appear to be responding to the potential investment unit reduction, with Seiko Group’s share price at ¥7,780 after a 7.31% 1 day share price return and a year...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Shareholders of PARK24 Co., Ltd. ( TSE:4666 ) will be pleased this week, given that the stock price is up 14% to...

Capcom (TSE:9697) stock is back in focus after a cluster of product announcements, including new expansions for Dragon’s Dogma 2 and Monster Hunter Wilds, a Resident Evil remake and a revived Onimusha installment. See our latest analysis for Capcom. The recent suite of franchise updates appears to have caught investors’ attention, with a 1-day share price return of 4.82% and a 7-day share price return of 3.17%. The share price is still down over the year to date, however, and the 1-year total...

Credit Saison (TSE:8253) has moved into focus after issuing fresh earnings guidance for the fiscal year ending March 2027 and outlining higher dividend plans, giving investors new data on expected cash flows and payouts. See our latest analysis for Credit Saison. The fresh earnings guidance and higher dividend plan appear to have fed into improving sentiment around Credit Saison, with a 1-day share price return of 3.34% and year to date share price return of 5.35%. At the same time, longer...

Kura Oncology and Kyowa Kirin recently reported encouraging long-term Phase 1/2 KOMET-007 results showing that investigational ziftomenib plus 7+3 chemotherapy produced high remission rates, deep molecular responses and a manageable safety profile in newly diagnosed NPM1-m or KMT2A-r acute myeloid leukemia. A distinctive feature of the data is the high rate of early, deep minimal residual disease negativity alongside low treatment-related mortality, highlighting the regimen’s potential to...

Collaboration news puts Sysmex stock in focus Sysmex (TSE:6869) is back on investors' radar after VolitionRx Limited announced a collaboration to optimize its Nu.Q NETs H3.1 assay on the Sysmex platform, targeting diseases linked to NETosis. See our latest analysis for Sysmex. At a share price of ¥1,424.5, Sysmex has seen modest positive share price momentum in the past month with a 1-month share price return of 3.11% and 90-day share price return of 2.85%, yet the 1-year total shareholder...

Dividend increase and new earnings guidance put Token stock in focus Token (TSE:1766) drew investor attention after proposing a higher cash dividend for the fiscal year ended April 2026, outlining further dividend growth guidance and releasing new consolidated earnings projections. See our latest analysis for Token. The dividend and guidance update arrived as Token's share price climbed 3.46% on the day to ¥12,570, yet remains down 13.90% year to date. The 3 year total shareholder return of...

TDK (TSE:6762) stock is back in focus after TDK Ventures backed Aston Power, a power delivery startup for AI and high performance computing data centers, highlighting TDK’s push into energy and AI infrastructure. See our latest analysis for TDK. Those AI and energy efforts are landing at a time when TDK’s ¥3,830 share price has been moving strongly, with a 30 day share price return of 28.63% and a 1 year total shareholder return of 151.51%. This suggests that momentum has been building over...

J.S.B.Co.Ltd (TSE:3480) has put up a punchy Q2 2026 print, with revenue of ¥29.1b and basic EPS of ¥297.64, set against trailing twelve month EPS growth of 14.1% and a 13.8% annualized earnings growth rate over five years. The company has seen quarterly revenue move from ¥27.0b in Q2 2025 to ¥29.1b in Q2 2026, while basic EPS shifted from ¥267.87 to ¥297.64 over the same period, with trailing twelve month revenue at ¥79.6b and basic EPS at ¥315.17. For investors, the combination of higher...

Kobe Bussan (TSE:3038) has put solid numbers on the table for Q2 2026, with revenue of ¥144.6b and basic EPS of ¥47.75, set against a trailing twelve month picture where earnings grew 46% and net profit margin reached 6% from 4.4% a year earlier. The company has seen quarterly revenue move from ¥139.9b in Q2 2025 to ¥144.6b in Q2 2026, while basic EPS over the same quarters went from ¥16.62 to ¥47.75, and trailing twelve month EPS stands at ¥153.90 on revenue of ¥565.6b. With earnings...

Kura Sushi (TSE:2695) opened Q2 2026 with revenue of ¥62.3 billion and net income of ¥759 million, set against a trailing twelve month EPS of ¥58.47 and net income of ¥3.49 billion that benefited from a sharp year over year earnings swing. The company has seen quarterly revenue move in a relatively tight band around the ¥59.1 billion to ¥64.1 billion range over the past six reporting periods. EPS has ranged from ¥1.82 to ¥18.95 per quarter, feeding into that higher trailing figure and helping...

Artificial intelligence in healthcare is moving from concept to real-world tools that help doctors read scans, tailor treatment plans, and run hospitals more efficiently. At the same time, central banks, inflation trends, and energy prices keep markets focused on quality growth stories. The Transformative AI Healthcare Stocks screener is designed to surface companies that sit at this intersection of medical needs and data-driven technology, where better diagnostics, research, and remote care...

Seven & i Holdings has announced an organizational overhaul, creating a new international business management office and international operations department to oversee markets outside Japan and North America, alongside several executive changes effective July 1. This restructuring highlights management’s effort to tighten global oversight and potentially sharpen execution in overseas convenience and retail operations. We’ll now examine how the new international business management office and...

Why the HORIBA stock story now starts with biopharma process control HORIBA (TSE:6856) has moved into focus after FUJIFILM announced a jointly developed inline Raman system that targets real-time control in biopharmaceutical manufacturing, with reported antibody yield gains of about 10% versus conventional methods. See our latest analysis for HORIBA. The FUJIFILM partnership arrives against a backdrop of strong momentum in HORIBA’s stock, with a 90 day share price return of 46.60% and a 1...

The Bank of Japan’s latest rate hike to about 1% has put funding costs, inflation risks and the yen back at the center of every Japan investor’s playbook. Higher rates and sticky price pressures can reward some business models and strain others, especially among large manufacturers with meaningful export activity. This article looks at three Japanese export oriented manufacturing stocks from our screener that appear closely exposed to these shifts, and explains how the new rate backdrop, bond...

Dividend Fortresses are built for investors who want income that can hold its ground while central banks, inflation trends and bond yields keep shifting. With oil prices, interest rate expectations and global trade flows all in focus, dependable 5%+ yields from resilient dividend payers can offer a different way to stay invested without relying solely on price moves. This screener filters for stocks that aim to combine high income potential with balance sheet strength and durability through...

AI Small Caps are catching fresh interest as central banks lean on data, bond markets re-price, and growth signals vary sharply from region to region. Instead of relying only on giants like Nvidia or Microsoft, many investors are looking at smaller AI-focused stocks that sit closer to early-stage advances in machine learning, automation, and data intelligence. This article walks through 3 examples from our AI Small Caps screener, explaining how each one fits into a world where inflation,...

Japan’s latest interest rate move, lifting the Bank of Japan’s main rate to 1% for the first time since 1995, is reshaping the risk and return trade‑offs across the country’s financial sector. Higher borrowing costs, a pressured yen and rising energy driven inflation are all feeding into how investors think about Japanese financial stocks. This article highlights 3 Japanese Financial Sector Stocks screener picks that are closely exposed to the news, explaining why some investors see them as...

When inflation, interest rates and energy costs keep shifting, big funds often crowd into the same large caps and overlook smaller companies with strong balance sheets and proven business models. That is where the High-Quality Undiscovered Gems screener comes in, focusing on small caps with solid fundamentals that many institutions have yet to seriously research. For investors looking for quality first rather than hype, this theme can be a way to find potential future leaders before they are...

As global markets navigate a landscape marked by cautious optimism around geopolitical developments and fluctuating energy prices, investors are keeping a close eye on inflation trends and central bank actions. Amidst this backdrop, dividend stocks can offer stability and income potential, making them an attractive option for those seeking to balance growth with regular returns in today's dynamic environment.

Citizen Watch (TSE:7762) has drawn fresh attention with the launch of its first Disney Moana themed timepiece, a limited-edition Eco-Drive model positioned at the intersection of character collectibles and branded watchmaking. See our latest analysis for Citizen Watch. At a share price of ¥2,347.0, Citizen Watch has seen strong momentum, with an 82.50% year to date share price return and a very large 5 year total shareholder return of 587.91%. This suggests investors are reacting positively...

Chiyoda (TSE:6366) is back on investor radars after recent share price moves. This is prompting a closer look at how its engineering focused business, returns profile, and current valuation metrics line up today. See our latest analysis for Chiyoda. At the current share price of ¥762.0, Chiyoda has experienced short term share price weakness, including a 90 day share price return that declined 37.95%. However, the 1 year total shareholder return is 114.04%, which points to strong longer term...

Japan’s latest rate hike to 1% has pushed the country into a new chapter for interest rates, the yen and financial stocks. For investors watching Japanese financial sector stocks, this shift may open fresh opportunities as well as fresh risks. This article looks at three Japanese financial stocks from a screener focused on companies with stronger balance sheets and healthier profiles, all exposed to the Bank of Japan’s policy change and related currency and bond market moves. You will see how...